Inhibikase Therapeutics I...

NASDAQ: IKT · Real-Time Price · USD
1.89
0.04 (2.16%)
At close: Jul 03, 2025, 1:04 PM
1.89
0.00%
After-hours: Jul 03, 2025, 01:04 PM EDT
2.16%
Bid 1.8
Market Cap 140.51M
Revenue (ttm) n/a
Net Income (ttm) -36.55M
EPS (ttm) -0.58
PE Ratio (ttm) -3.26
Forward PE -3.79
Analyst Hold
Ask 2.18
Volume 81,965
Avg. Volume (20D) 254,731
Open 1.87
Previous Close 1.85
Day's Range 1.80 - 1.90
52-Week Range 1.12 - 4.20
Beta 0.94

About IKT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IKT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
7 months ago
-13.14%
Inhibikase Therapeutics shares are trading lower. ... Unlock content with Pro Subscription
7 months ago
+3.6%
Inhibikase Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced an $8 price target.